2012598-41-1
2012598-41-1
Chemical Structure
Acipimox-13C2,15N2
Synonym(s): K-9321-13C2,15N2
- CAS No.: 2012598-41-1
- Formula:C413C2H615N2O3
- Molecular Weight:158.10
InChIKey: DJQOOSBJCLSSEY-WKHKRNGSSA-N
SMILES: O=[13C]([13C]1=C[15N+]([O-])=C(C)C=[15N]1)O
Biological Activity: Acipimox-13C2,15N2 (K-9321-13C2,15N2) is 13C- and 15N-labeled Acipimox (HY-B0283)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Acipimox-13C2,15N2 | Acipimox-13C2,15N2 (K-9321-13C2,15N2) is 13C- and 15N-labeled Acipimox (HY-B0283). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acipimox (Standard) | ≥98% | Acipimox (Standard) is the analytical standard of Acipimox. This product is intended for research and analytical applications. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acipimox-d4 | Acipimox-d4 is the deuterium labeled Acipimox. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox acutely inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acipimox | 99.58% | Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
